Page last updated: 2024-09-05

anidulafungin and Disease Models, Animal

anidulafungin has been researched along with Disease Models, Animal in 34 studies

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (32.35)	29.6817
2010's	20 (58.82)	24.3611
2020's	3 (8.82)	2.80

Authors

Authors	Studies
Andes, D; Ashbeck, J; Diekema, DJ; Hou, J; Marchillo, K; Pfaller, MA; Prince, RA	1
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, J; Sheehan, DJ	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1
An, MM; Chen, SM; Guo, SY; Hou, WT; Hu, XY; Jiang, YY; Qiu, XR; Shen, H; Song, LJ; Zhang, Y; Zou, Z	1
Adeojo, LW; Alfaro, R; Ashbaugh, A; Cushion, MT; Kovacs, JA; Kumar, P; Lu, R; Mannino, R; Tramont, E	1
Bedin Denardi, L; de Azevedo, MI; Hartz Alves, S; Keller, JT; Morais Santurio, J; Oliveira, V; Pantella Kunz de Jesus, F; Weiblen, C	1
Bordallo-Cardona, MÁ; Bouza, E; Cantón, R; de la Pedrosa, EG; Díaz-García, J; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Holtappels, M; Kucharíková, S; Lagrou, K; Lamkanfi, M; Rogiers, O; Siala, W; Van Bambeke, F; Van Dijck, P	1
Borghi, E; Cirasola, D; Morace, G; Ricucci, V; Sciota, R; Vizzini, L	1
Capilla, J; Guarro, J; Mayayo, E; Pastor, FJ; Sanchis, M	1
Ghannoum, M; Katragkou, A; Petraitis, V; Roilides, E; Walsh, TJ	1
Katragkou, A; Roilides, E; Walsh, TJ	1
Capilla, J; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, NP	1
Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I	1
Capilla, J; Guarro, J; Martin-Vicente, A	1
Cantón, E; Gobernado, M	1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W	1
Chandrasekar, PH; Cutright, JL; Krishnan-Natesan, S; Manavathu, EK	1
Hou, J; Kontoyiannis, DP; Lewis, RE; Liao, G; Prince, RA	1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ	1
Benjamin, DK; Cohen-Wolkowiez, M; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, S; Livermore, J; Petraitiene, R; Petraitis, V; Sharp, A; Walsh, TJ; Warn, PA	1
Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Wiederhold, NP	1
Barchiesi, F; Giannini, D; Manso, E; Orlando, F; Posteraro, B; Sanguinetti, M; Spreghini, E	1
Arendrup, MC; Goodwin, J; Hope, W; Howard, SJ; Jensen, RH; Perlin, DS	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE	1
Abbott, J; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Livermore, JL; Sharp, A; Warn, PA	1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE	1
Cornely, OA; Karthaus, M; Kümmerle, T; Vehreschild, JJ	1
Edwards, JE; Fu, Y; Gebremariam, T; Ibrahim, AS; Spellberg, B	1
Guarro, J; Pastor, FJ	1
Clemons, KV; Sobel, RA; Stevens, DA	1
Andriole, VT; Marino, S; Roberts, J; Schock, K	1
Bacher, JS; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ	1

Reviews

4 review(s) available for anidulafungin and Disease Models, Animal

Article	Year
Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Catheter-Related Infections; Disease Models, Animal; Echinocandins; Fungi; Humans; Immunomodulation; Microbial Sensitivity Tests; Mucous Membrane; Mycoses	2015
[Anidulafungin]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2008, Volume: 21, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Humans; Mycoses	2008
Anidulafungin--state of affairs from a clinical perspective. Mycoses, 2007, Volume: 50 Suppl 1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Drug Interactions; Echinocandins; Humans; Rabbits	2007
[Anidulafungin: experimental therapy of fungal infections in animal models]. Revista iberoamericana de micologia, 2008, Volume: 25, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Lung Diseases, Fungal	2008

Other Studies

30 other study(ies) available for anidulafungin and Disease Models, Animal

Article	Year
In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Treatment Outcome	2008
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Kidney; Male; Mice	2009
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020
Preventing Emerging microbes & infections, 2020, Volume: 9, Issue:1 Topics: Anidulafungin; Animals; Antibodies, Monoclonal; Antifungal Agents; Caco-2 Cells; Candida albicans; Candidemia; Disease Models, Animal; Drug Synergism; Endothelial Cells; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Human Umbilical Vein Endothelial Cells; Humans; Mice; Phosphopyruvate Hydratase; Plasminogen; Protein Binding; Protein Structure, Secondary	2020
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia. The Journal of infectious diseases, 2021, 07-15, Volume: 224, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Atovaquone; Disease Models, Animal; Mice; Pneumonia, Pneumocystis	2021
Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus. Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lung; Mice; Pulmonary Aspergillosis; Treatment Outcome; Triazoles	2018
Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata. Medical mycology, 2018, Oct-01, Volume: 56, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Disease Models, Animal; DNA Mutational Analysis; Drug Resistance, Fungal; Glucosyltransferases; Lepidoptera; Micafungin; Mutation; Survival Analysis	2018
Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies. The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10 Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Coinfection; Disease Models, Animal; Drug Synergism; Flow Cytometry; Foreign Bodies; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Treatment Outcome	2018
Experimental biofilm-related Candida infections. Future microbiology, 2013, Volume: 8, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Larva; Lepidoptera; Survival Analysis; Treatment Outcome	2013
Experimental efficacy of anidulafungin against Aspergillus terreus species complex. Medical mycology, 2015, Volume: 53, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Disease Models, Animal; Echinocandins; Humans; Kidney; Mice	2015
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices	2015
Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa. Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:1 Topics: Anidulafungin; Animal Structures; Animals; Antifungal Agents; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fungemia; Lipopeptides; Male; Mice; Saccharomycetales; Survival Analysis; Treatment Outcome	2016
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model. Current eye research, 2017, Volume: 42, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole	2017
Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis. Medical mycology, 2017, Jun-01, Volume: 55, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Kidney; Male; Mice; Survival Analysis; Triazoles	2017
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole	2009
Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Neutropenia; Spleen; Treatment Outcome	2010
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Lipopeptides; Mice; Mice, Inbred BALB C; Treatment Outcome	2011
Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo. International journal of antimicrobial agents, 2011, Volume: 38, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus niger; Colony Count, Microbial; Disease Models, Animal; Drug Evaluation, Preclinical; Echinocandins; Male; Mice; Microbial Sensitivity Tests; Survival Rate; Treatment Outcome	2011
Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Meningitis, Fungal; Meningoencephalitis; Monte Carlo Method; Rabbits; Treatment Outcome	2012
Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Blood; Blood Chemical Analysis; Candida albicans; Candidiasis, Invasive; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluconazole; Mice; Mice, Inbred ICR; Neutropenia; Proteoglycans; Survival Analysis; Treatment Outcome	2012
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Candida glabrata; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Kidney; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Dosage Calculations; Echinocandins; Endophthalmitis; Kidney; Male; Models, Biological; Rabbits; Vitreous Body	2013
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2013
Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liposomes; Male; Micafungin; Mice; Mice, Inbred BALB C; Mucormycosis; Polyenes; Rhizopus; Treatment Outcome	2008
Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Interactions; Echinocandins; Glucocorticoids; Male; Mice; Mice, Inbred DBA; Peptides, Cyclic	2000
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12 Topics: Anidulafungin; Animals; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Disease Models, Animal; Echinocandins; Liver; Lung; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles	2000
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Rabbits; Tissue Distribution	2001